Senopsys, LLC   Report issue

For profit Phase 1
Founded: Woburn MA United States (2006)

Organization Overview

First Clinical Trial
2015
NCT02608918
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Senopsys

Active Ingredients

Drugs in Phase 1 Trials (2)

bms955176 (1 trial)

tricaprylyl glycerol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2